Product News: OxyContin

Share this article:
FDA approved a new formulation of OxyContin, an opoid analgesic manufactured by Purdue Pharma. The new formulation aims to stem abuse of the drug by making it more difficult to cut, break or crush the pill.
Share this article:

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.